Previous close | 19.00 |
Open | 19.00 |
Bid | 18.50 |
Ask | 22.90 |
Strike | 85.00 |
Expiry date | 2024-09-20 |
Day's range | 19.00 - 19.00 |
Contract range | N/A |
Volume | |
Open interest | 1 |
While Bruker Corporation ( NASDAQ:BRKR ) shareholders are probably generally happy, the stock hasn't had particularly...
Bruker's (BRKR) neofleX is a versatile, high-performance and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers.
ANAHEIM, Calif., June 03, 2024--At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) launches the new top-of-the-line timsTOF Ultra 2 system with significantly further enhanced sensitivity for deep profiling of small cells, subcellular organelles, as well as increased sample loading flexibility. Together with new Spectronaut 19 software and the novel PreOmics ENRICHplus kit, Bruker is setting new 4D-Proteomics standards from highest sensitivity to large-scale, deep plasma proteomics. Bruk